ochratoxin a has been researched along with Enteritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, C; Liu, X; Meng, F; Shen, W; Wang, S; Yan, C; Zhang, Y | 1 |
| Chunlei, W; Cuiling, P; Hong, W; Kehe, H; Nianhui, Z; Ying, C | 1 |
2 other study(ies) available for ochratoxin a and Enteritis
| Article | Year |
|---|---|
Ochratoxin A promotes chronic enteritis and early colorectal cancer progression by targeting Rinck signaling.
Topics: Animals; Chronic Disease; Colitis; Colonic Neoplasms; Colorectal Neoplasms; Dextran Sulfate; Disease Models, Animal; Enteritis; Humans; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; Mice, Transgenic; NF-E2-Related Factor 2; Rabbits; Ubiquitins | 2024 |
Nontoxic concentrations of OTA aggravate DON-induced intestinal barrier dysfunction in IPEC-J2 cells via activation of NF-κB signaling pathway.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Claudin-3; Claudin-4; Cytokines; Dose-Response Relationship, Drug; Electric Impedance; Enteritis; Intestinal Mucosa; NF-kappa B; Ochratoxins; Permeability; Signal Transduction; Sus scrofa; Tight Junctions; Time Factors; Trichothecenes | 2019 |